Dow Jones Top Company Headlines at 1 PM ET: Union Pacific, Norfolk Southern Refile Rail-Merger Application | Eli ...

Dow Jones01:00

Union Pacific, Norfolk Southern Refile Rail-Merger Application

Latest application says the merged railroad would have a 39% market share and provides conditions under which Union Pacific would walk away from the tie-up.

----

Eli Lilly Shares Jump 10% as Mounjaro, Zepbound Fuel Massive Growth

Surging consumer demand for blockbuster weight-loss drugs helped offset their declining prices.

----

Caterpillar Lifts Outlook as AI-Fueled Power Demand Persists

Caterpillar said demand for its construction equipment, engines and generators remains strong despite rising geopolitical tensions and higher energy prices.

----

Cigna to Exit Affordable Care Act Market, Adding to Tumult

The move follows Aetna's departure from the ACA market, which has seen significantly declining membership amid rising premium bills.

----

Blue Owl Expands Other Businesses With Private Credit in Turmoil

The company reported stronger fundraising for its smaller businesses in the first quarter, offsetting stalled growth in its flagship private-credit unit.

----

Elon Musk Takes The Stand for a Third Day in Lawsuit Against Sam Altman

OpenAI President Greg Brockman and Musk's fixer, Jared Birchall, are also expected to testify on Thursday.

----

Mastercard Profit, Sales Rise as Payment Network Arm Grows

The credit-card company posted a profit of $3.88 billion, or $4.35 a share, in the quarter ended March 31, compared with $3.28 billion, or $3.59 a share, a year earlier.

----

Hershey Profit Jumps as Price Hikes Boost Sales

Hershey reported higher first-quarter profit as price increases announced last year provided a boost to revenue, even as its sales volume declined.

----

Cigna Revenue Rises on Evernorth Growth

Cigna Group logged higher profit and revenue in its latest quarter as its pharmacy-benefit business Evernorth continued to grow.

----

International Paper Swings to Profit, Issues Downbeat Outlook

International Paper swung to a first-quarter profit as it prepares to split its North American operations from its overseas business.

----

Activist Hedge Fund Makes Nearly $3 Billion Offer to Buy Meineke Owner

ADW Capital says private-equity firm Roark Capital is mismanaging Driven and offers a roughly 40% premium to buy the company.

----

Cardinal Health Lifts Outlook Again as Revenue Rises

Cardinal Health once again raised its full-year outlook after logging higher-than-expected adjusted earnings in the third quarter .

----

Altria Sales Rise, Boosted by Higher Cigarette Prices

Altria posted higher sales in the first quarter as higher pricing offset lower volumes.

----

Wayfair's Market Share Holds Despite Furniture-Industry Slowdown

Wayfair said the year is off to a rocky start as consumers are pulling back on nonessential spending.

----

Bombardier Lifts Outlook as Services Segment Drives Revenue, Cash Flow Higher

The company's services unit generated $617 million in the first quarter, helping push overall sales up 5%.

----

ConocoPhillips Cuts Outlook, Logs Lower Earnings

ConocoPhillips reported a first-quarter profit of $2.18 billion, or $1.78 a share, down from a year earlier, amid lower gas prices in Permian and lower volumes.

----

Gildan Activewear Revenue Climbs

Gildan Activewear posted higher first-quarter sales as the company began folding in results from its newly acquired HanesBrands business.

----

Textron to Separate Industrial Arm in Shift to Aerospace Focus

The Providence, R.I., company said Thursday it will explore options for the industrial unit, including a potential sale or tax-free spinoff into a publicly traded company.

----

Blackstone Adds New Unit to Focus Its AI Momentum

Called BXN1, the new arm will concentrate some of the firm's AI bets as it also underscores Stephen Schwarzman's conviction in the technology.

----

Merck First-Quarter Sales Rise on Continued Keytruda Growth

The company's quarterly sales rose 5% to $16.29 billion, boosted by 12% growth for its flagship Keytruda cancer drug.

 

(END) Dow Jones Newswires

April 30, 2026 13:00 ET (17:00 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment